SGB, Yulex Collaborate on Genomic Program to Develop Guayule as Biorubber Source | GenomeWeb

NEW YORK (GenomeWeb News) – SGB and Yulex today said they will be collaborating on the creation of a genomics and molecular breeding program to accelerate the crop improvement of guayule as a sustainable source of biorubber.

The collaboration seeks to develop guayule as a replacement for tropical or petroleum-based rubber for medical, consumer, and industrial markets. Guayule is an industrial crop that does not compete with food or fiber crops. It requires low inputs and is a renewable source of natural rubber.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.